الفهرس 
L-CarnitineOnly 14 pages are availabe for public view
 |  | from | 130 |  |  |
| | | from | 130 | | |
Abstract
The addition of L-carnitine to the conventional therapy of patients with dilated cardiomyopathy showed subjective improvement in symptoms, together with objective evidence of absence of edema lower limb, reduction in cardiac chamber dimensions and increase in ejection fraction and fractional shortening